ArticleFrontiers in psychiatry2026
Association between first-trimester serum 25(OH)D and EPDS-positive postpartum depressive symptoms in women with gestational diabetes mellitus: a retrospective cohort study.
Article in Frontiers in psychiatry, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
6 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Introduction: Gestational diabetes mellitus (GDM) has been associated with an increased risk of postpartum depressive symptoms, while maternal vitamin D status may also be related to perinatal mood disturbances. This study investigated the association between first-trimester serum 25-hydroxyvitamin D [25(OH)D] concentrations and Edinburgh Postnatal Depression Scale (EPDS)-positive postpartum depressive symptoms in women with GDM. Methods: This retrospective cohort study included 242 women with GDM. Prenatal depressive and anxiety symptoms were assessed using the Patient Health Questionnaire-9 (PHQ-9) and Generalized Anxiety Disorder-7 (GAD-7), respectively. Sequential logistic regression models were adjusted for baseline maternal characteristics, prenatal PHQ-9 and GAD-7 scores, and glycated hemoglobin A1c (HbA1c). Results: Among 242 women, 69 had EPDS-positive postpartum depressive symptoms. Each 5-ng/mL increase in 25(OH)D was associated with lower odds of EPDS-positive symptoms in the crude model (OR 0.35, 95% CI 0.25-0.48) and after adjustment for baseline characteristics (adjusted OR 0.36, 95% CI 0.25-0.50). After additional adjustment for prenatal PHQ-9 and GAD-7 scores, the association was attenuated and was no longer statistically significant overall (adjusted OR 0.69, 95% CI 0.43-1.12; P = 0.134). Additional adjustment for HbA1c produced similar results. Exploratory stratified analyses using the full Model 2 covariate set showed no statistically significant associations within strata defined by pre-pregnancy BMI, hypertensive disorders of pregnancy, or insulin use, and no significant interactions were detected. Discussion: These findings suggest that the overall association between first-trimester 25(OH)D and postpartum depressive symptoms was substantially influenced by prenatal mental health status and was not consistently demonstrated after comprehensive covariate adjustment.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.